In June, Sun Pharma will close a plant operated in Detroit by its U.S. subsidiary, Caraco Pharmaceutical Laboratories. About 180 employees will lose their jobs. The plant has a checkered past. Between 2009 and 2012, FDA forbade the plant from making drugs after it discovered manufacturing deficiencies. Prior to the manufacturing ban, the Detroit plant produced about $110 million worth of drugs annually.